Logo for EpiBone

Meet an Unreasonable Venture


Creating bone tissue from a patient's mesenchymal stem cells in vitro for use in bone grafts.

Photo of Nina Tandon

Nina Tandon

CEO & Co-Founder at EpiBone

More about Nina »
Employees 21–50
Headquarters New York, New York, United States
EpiBone is a revolutionary bone reconstruction company that allows patients to “grow their own bone”. EpiBone’s pioneering technology utilizes a scan of the patient’s bone defect and the patient’s own stem cells to construct and cultivate a defect-specific autologous-like bone graft. EpiBone is strategically positioned to provide a superior bone graft that will provide exact defect repair, a simplified surgical procedure, improved bone formation and regeneration, and shorter recovery times, without the complications of foreign body implantation, to the over 900,000 patients who undergo bone-related surgeries each year.

Currently Operating in One Region

Press Mentions

October 17, 2015

Why Peter Thiel Invested In New York Biotech Startup EpiBone

More Ventures in Health

Get the Unreasonable Newsletter

Get twice-monthly updates on EpiBone and over 314 other ventures working to solve the world's toughest problems.

Read our Privacy Policy.